organization · Reporting owner
Reprogrammed Interchange LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vor Biopharma Inc.VOR · Entity 4763 | 10% owner | October 17, 2025 | October 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vor Biopharma Inc.
Report date October 17, 2025 · Filed October 21, 2025
Jointly reported with Hoffman Reid
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,166,909 |
Last balance in matching sequence
After 2025-10-21 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2025-10-17 · Sale · Disposed 24,689 · Balance 1,179,753 F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 2 · 2025-10-17 · Sale · Disposed 1,028 · Balance 1,178,725 F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 3 · 2025-10-20 · Sale · Disposed 11,616 · Balance 1,167,109 F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 4 · 2025-10-21 · Sale · Disposed 200 · Balance 1,166,909 F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.
F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2025 Filed Oct 21, 2025 17:45 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 200 | $30.08 | $6,015.00 |
DisclosureSEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,166,909 F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 20, 2025 Filed Oct 21, 2025 17:45 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 11,616 | $30.05 | $349,101.46 |
DisclosureSEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,167,109 F3 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 17:45 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 1,028 | $31.00 | $31,868.00 |
DisclosureSEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,178,725 F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 17:45 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 24,689 | $30.22 | $746,118.86 |
DisclosureSEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,179,753 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 16, 2025 Filed Oct 17, 2025 18:33 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 2,021 | $30.45 | $61,549.15 |
DisclosureSEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,204,442 F5 · price: This transaction was executed in multiple trades at prices ranging from $30.05 to $30.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:33 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 7,894 | $32.77 | $258,712.43 |
DisclosureSEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,206,463 F4 · price: This transaction was executed in multiple trades at prices ranging from $32.51 to $33.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:33 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 48,910 | $32.05 | $1,567,364.97 |
DisclosureSEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,214,357 F3 · price: This transaction was executed in multiple trades at prices ranging from $31.51 to $32.505. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:33 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 14,851 | $31.05 | $461,117.61 |
DisclosureSEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,263,267 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.505 to $31.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 14, 2025 Filed Oct 15, 2025 18:32 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 33,668 | $30.32 | $1,020,786.83 |
DisclosureSEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,278,118 F5 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 18:32 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 2,334 | $33.09 | $77,225.76 |
DisclosureSEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,311,786 F4 · price: This transaction was executed in multiple trades at prices ranging from $33.00 to $33.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 18:32 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 19,672 | $32.36 | $636,560.35 |
DisclosureSEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,314,120 F3 · price: This transaction was executed in multiple trades at prices ranging from $32.00 to $32.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 18:32 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 40,983 | $30.97 | $1,269,132.86 |
DisclosureSEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333,792 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.68 to $31.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 17:51 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 15,042 | $32.41 | $487,439.02 |
DisclosureSEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,374,775 F5 · price: This transaction was executed in multiple trades at prices ranging from $32.26 to $32.855. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 17:51 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 33,842 | $31.92 | $1,080,172.34 |
DisclosureSEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389,817 F4 · price: This transaction was executed in multiple trades at prices ranging from $31.26 to $32.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 17:51 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 14,336 | $34.34 | $492,285.34 |
DisclosureSEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,423,659 F3 · price: This transaction was executed in multiple trades at prices ranging from $34.20 to $34.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 17:51 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 60,926 | $33.75 | $2,056,471.83 |
DisclosureSEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437,995 F1 · price: This transaction was executed in multiple trades at prices ranging from $33.20 to $34.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 07, 2025 Filed Oct 8, 2025 17:20 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 27,624 | $33.84 | $934,710.53 |
DisclosureSEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,498,921 F5 · price: This transaction was executed in multiple trades at prices ranging from $33.70 to $34.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 17:20 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 18,156 | $37.77 | $685,830.19 |
DisclosureSEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,526,545 F4 · price: This transaction was executed in multiple trades at prices ranging from $37.59 to $38.18 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 17:20 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 34,847 | $37.12 | $1,293,565.94 |
DisclosureSEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544,701 F3 · price: This transaction was executed in multiple trades at prices ranging from $36.59 to $37.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 17:20 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 17,760 | $36.00 | $639,391.97 |
DisclosureSEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579,548 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.59 to $36.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 03, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 4,701 | $38.14 | $179,316.82 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 8 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,597,308 F10 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to $38.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 03, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 3,200 | $37.37 | $119,593.92 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 7 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,602,009 F9 · price: This transaction was executed in multiple trades at prices ranging from $36.88 to $37.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 5,300 | $42.32 | $224,290.70 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 6 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,605,209 F8 · price: This transaction was executed in multiple trades at prices ranging from $42.00 to $42.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 13,001 | $40.13 | $521,706.73 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 5 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,610,509 F7 · price: This transaction was executed in multiple trades at prices ranging from $39.86 to $40.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 7,700 | $39.57 | $304,710.56 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,623,510 F6 · price: This transaction was executed in multiple trades at prices ranging from $39.20 to $39.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 1,513 | $38.38 | $58,064.55 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,631,210 F5 · price: This transaction was executed in multiple trades at prices ranging from $37.85 to $38.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 4,937 | $37.21 | $183,684.54 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,632,723 F4 · price: This transaction was executed in multiple trades at prices ranging from $36.82 to $37.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 21:12 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 1,400 | $39.19 | $54,869.50 |
DisclosureSEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,637,660 F1 · price: This transaction was executed in multiple trades at prices ranging from $39.11 to $39.415. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The number of shares beneficially owned reflects the 1-for-20 reverse stock split effected September 18, 2025. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 20:40 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 447,278 | $1.54 | $688,852.85 |
DisclosureSEC source: 0002050755-25-000008 · form4-09192025_120912.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,781,209 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.52 to $1.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 15, 2025 Filed Sep 15, 2025 17:17 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 400,000 | $1.64 | $656,320.00 |
DisclosureSEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,228,487 F4 · price: This transaction was executed in multiple trades at prices ranging from $1.57 to $1.765. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 17:17 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 300,000 | $1.75 | $526,230.00 |
DisclosureSEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,628,487 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.73 to $1.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 17:17 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 284,805 | $1.83 | $521,420.99 |
DisclosureSEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,928,487 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.81 to $1.855. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 10, 2025 Filed Sep 10, 2025 20:27 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 350,000 | $1.82 | $635,285.00 |
DisclosureSEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,213,292 F4 · price: This transaction was executed in multiple trades at prices ranging from $1.80 to $1.935. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 20:27 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 449,226 | $2.00 | $898,631.69 |
DisclosureSEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,563,292 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.97 to $2.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 20:27 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 464,421 | $1.99 | $924,058.46 |
DisclosureSEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,012,518 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.97 to $2.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 05, 2025 Filed Sep 5, 2025 18:51 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 400,000 | $1.97 | $787,280.00 |
DisclosureSEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,476,939 F4 · price: This transaction was executed in multiple trades at prices ranging from $1.935 to $1.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 18:51 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 453,016 | $1.93 | $873,641.36 |
DisclosureSEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,876,939 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.91 to $2.005. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 18:51 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 554,612 | $2.00 | $1,107,061.01 |
DisclosureSEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,329,955 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.99 to $2.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 18:05 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 806,351 | $2.01 | $1,621,975.04 |
DisclosureSEC source: 0001415889-25-023318 · form4-08292025_100808.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,884,567 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.95 to $2.075. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 18:05 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 611,647 | $2.01 | $1,226,535.73 |
DisclosureSEC source: 0001415889-25-023318 · form4-08292025_100808.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,690,918 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.99 to $2.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| August 26, 2025 Filed Aug 27, 2025 17:25 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 284,190 | $2.08 | $591,342.55 |
DisclosureSEC source: 0001415889-25-023165 · form4-08272025_090848.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,302,565 F3 · price: This transaction was executed in multiple trades at prices ranging from $2.06 to $2.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 17:25 UTC | Vor Biopharma Inc. VOR · Entity 4763 | SaleCommon Stock | 387,346 | $2.12 | $819,740.34 |
DisclosureSEC source: 0001415889-25-023165 · form4-08272025_090848.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,586,755 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.05 to $2.215. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 19:42 UTC | Vor Biopharma Inc. VOR · Entity 4763 | PurchaseWarrant (Right to Buy) · Derivative | 48,717,626 | Not disclosed Strike: $0.84 | Not disclosed |
DisclosureSEC source: 0001415889-25-000220 · form4-01032025_120101.xml · derivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,717,626 Underlying: Common Stock · 48,717,626 shares Expires 2031-12-30 F1 · price: Each share of Common Stock was purchased together with an accompanying Warrant to purchase 1.25 shares of Common Stock. The purchase price of the securities was $0.99425 per share and accompanying Warrant. F3 · derivative.exercise_date: The Warrants are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Warrants to the extent that such exercise would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Person, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 19:42 UTC | Vor Biopharma Inc. VOR · Entity 4763 | PurchaseCommon Stock | 38,974,101 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-000220 · form4-01032025_120101.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,974,101 F1 · price: Each share of Common Stock was purchased together with an accompanying Warrant to purchase 1.25 shares of Common Stock. The purchase price of the securities was $0.99425 per share and accompanying Warrant. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.